Encephalopathy in acute liver failure resulting from acetaminophen intoxication: New observations with potential therapy

Critical Care Medicine

Volumn 39, Issue 11, 2011, Pages 2550-2553

  Brusilow, Saul W ^a   Cooper, Arthur J L ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

acetaminophen poisoning; acute liver failure; astrocytes; encephalopathy; hyperammonemia; intracranial pressure; osmotic stress; plasma ammonia; plasma glutamine

Indexed keywords

ACETYLCYSTEINE; AMMONIA; ASPARTATE AMINOTRANSFERASE; GLUTAMINE; PARACETAMOL;

ACUTE LIVER FAILURE; ADULT; AGITATION; AMMONIA BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASTROCYTE; BRAIN EDEMA; CASE REPORT; CONFUSION; DECEREBRATION; DRUG INTOXICATION; DRUG OVERDOSE; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; HYPERAMMONEMIA; INTRACRANIAL HYPERTENSION; IRRITABILITY; LIVER FUNCTION; MENTAL HEALTH; OSMOTIC STRESS; PHYSICAL EXAMINATION; PRIORITY JOURNAL;

EID: 80054939744     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31822572fd     Document Type: Article

References (41)

1. Khashab M, Tector AJ, Kwo PY: Epidemiology of acute liver failure. Curr Gastroenterol Rep 2007; 9:66-73 (Pubitemid 46487027)
2. Lee WM: Acetaminophen and the US Acute Liver Failure Study Group: Lowering the risks of hepatic failure. Hepatology 2004; 40: 6-9 (Pubitemid 38868915)
3. Vaquero J, Butterworth RF: Mechanisms of brain edema in acute liver failure and impact of novel therapeutic interventions. Neurol Res 2007; 29:683-690 (Pubitemid 350086067)
4. Cooper AJL, Plum F: Biochemistry and physiology of brain ammonia. Physiol Rev 1987; 67:440-519 (Pubitemid 17063608)
5. Brusilow SW: Urea cycle disorders: Clinical paradigm of hyperammonemic encephalopathy. Prog Liver Dis 1995; 13:293-309
6. Mitchell RB, Wagner JE, Karp JE, et al: Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med 1988; 85:662-667 (Pubitemid 19015720)
7. Nott L, Price TJ, Pittman K, et al: Hyperammonemia encephalopathy: An important cause of neurological deterioration following chemotherapy. Leuk Lymphoma 2007; 48: 1702-1711 (Pubitemid 47386705)
8. Samtoy B, DeBeukelaer MM: Ammonia encephalopathy secondary to urinary tract infection with Proteus mirabilis. Pediatrics 1980; 65:294-297 (Pubitemid 10068590)
9. Sato S, Yokota C, Toyoda K, et al: Hyperammonemic encephalopathy caused by urinary tract infection with urinary retention. Eur J Intern Med 2008; 19:e78-e79
10. Vossler DG, Wilensky AJ, Cawthon DF, et al: Serum and CSF glutamine levels in valproate-related hyperammonemic encephalopathy. Epilepsia 2002; 43:154-159 (Pubitemid 34225995)
11. Segura-Bruna N, Rodriguez-Campello A, Puente V, et al: Valproate-induced hyperammonemic encephalopathy. Acta Neurol Scand 2006; 114:1-7 (Pubitemid 43873517)
12. Lamiell JJ, Ducey JP, Freese-Kepczyk BJ, et al: Essential amino acid-induced adult hyperammonemic encephalopathy and hypophosphatemia. Crit Care Med 1990; 18:451-452 (Pubitemid 20138332)
13. Raichle ME, Larson KB: The significance of the NH3-NH4+ equilibrium on the passage of 13N-ammonia from blood to brain. A new regional residue detection model. Circ Res 1981; 48:913-937 (Pubitemid 11126080)
14. Cooper AJL, McDonald JM, Gelbard AS, et al: The metabolic fate of 13N-labeled ammonia in rat brain. J Biol Chem 1979; 254: 4982-4992 (Pubitemid 9227452)
15. Cooper AJL, Mora SN, Cruz NF, et al: Cerebral ammonia metabolism in hyperammonemic rats. J Neurochem 1985; 44:1716-1723 (Pubitemid 15000274)
16. Martinez-Hernandez A, Bell KP, Norenberg MD: Glutamine synthetase: Glial localization in brain. Science 1977; 195:1356-1358 (Pubitemid 8056735)
17. Norenberg MD, Martinez-Hernandez A: Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 1979; 161:303-310 (Pubitemid 9087410)
18. Martinez A: Electron microscopy in human hepatic encephalopathy. Acta Neuropath 1968; 11:82-86
19. Zamora AJ, Cavanagh JB, Kyu MH: Ultrastructural responses of the astrocytes to portacaval anastomosis in the rat. J Neurol Sci 1973; 18:25-45
20. Norenberg MD, Lapham LW: The astrocyte response in experimental portal systemic encephalopathy. An electron microscopic study. J Neuropath Exp Neurol 1974; 33:422-435
21. Voorhies TM, Ehrlich ME, Duffy TE, et al: Acute hyperammonemia in the young primate: Physiologic and neuropathologic correlates. Pediatr Res 1983; 17:970-975 (Pubitemid 14209287)
22. Norenberg MD: Astrocyte responses to CNS injury. J Neuropath Exp Neurol 1994; 53: 213-220 (Pubitemid 24146858)
23. Willard-Mack CL, Koehler RC, Hirata T, et al: Inhibition of glutamine synthetase reduces ammonia-induced astrocyte swelling in rat. Neuroscience 1996; 71:589-599 (Pubitemid 26067021)
24. Brusilow SW, Koehler RC, Traystman RJ, et al: Astrocyte glutamine synthetase: Importance in hyperammonemic syndromes and potential target for therapy. Neurotherapeutics 2010; 7:452-470
25. Brusilow SW, Traystman RJ: Hepatic encephalopathy. N Engl J Med 1986; 314:786-787
26. Rovira A, Alonso J, Córdoba J: MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol 2008; 29:1612-1621
27. Stravitz RT, Kramer AH, Davern T, et al: Acute Liver Failure Group: Intensive care of patients with acute liver failure: Recommendations of the Acute Liver Failure Study Group. Crit Care Med 2007; 35:2498-2508 (Pubitemid 351339009)
28. Paleologos M, Stone E, Braude S: Persistent, progressive hypophosphataemia after voluntary hyperventilation. Clin Sci (Lond) 2000; 98:619-625 (Pubitemid 30261013)
29. Matheson DF, Van Den Berg CJ: Ammonia and brain glutamine: Inhibition of glutamine degradation by ammonia. Biochem Soc Trans 1975; 3:525-528
30. Giguère JF, Butterworth RF: Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy. Neurochem Res 1984; 9:1309-1321 (Pubitemid 14006681)
31. Record CO, Buxton B, Chase RA, et al: Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 1976; 6:387-394
32. Tofteng F, Hauerberg J, Hansen BA, et al: Persistent arterial hyperammonemia increases the concentration of glutamine and alanine in the brain and correlates with intracranial pressure in patients with fulminant hepatic failure. J Cereb Blood Flow Metab 2006; 26:21-27 (Pubitemid 41818066)
33. Scholl-Bürgi S, Baumgartner Sigl S, Häberle J, et al: Amino acids in CSF and plasma in hyperammonaemic coma due to arginase1 deficiency. J Inherit Metab Dis 2008 Dec 6
34. Felig P, Wahren J, Ahlborg G: Uptake of individual amino acids by the human brain. Proc Soc Exp Biol Med 1973; 142: 230-231
35. Berg A, Bellander BM, Wanecek M, et al: The pattern of amino acid exchange across the brain is unaffected by intravenous glutamine supplementation in head trauma patients. Clin Nutr 2008; 27:816-821
36. Lund P: Control of glutamine synthesis in rat liver. Biochem J 1971; 124:653-600
37. Xiang J, Ennis SR, Abdelkarim GE, et al: Glutamine transport at the blood-brain and blood-cerebrospinal fluid barriers. Neurochem Int 2003; 43:279-288 (Pubitemid 36561279)
38. Wu C: Glutamine synthetase-I. A comparative study of its distribution in animals and its inhibition by DL-allo-δ-hydroxylysine. Comp Biochem Physiol 1963; 8:335-351
39. Miller JD: Volume and pressure in the craniospinal axis. Clin Neurosurg 1975; 22: 76-105
40. Mokri B: The Monro-Kellie hypothesis: Applications in CSF volume depletion. Neurology 2001; 56:1746-1748 (Pubitemid 32574577)
41. Griffith OW, Meister A: Differential inhibition of glutamine and γ-glutamylcysteine synthetases by α-alkyl analogs of methionine sulfoximine that induce convulsions. J Biol Chem 1978; 253:2333-2338 (Pubitemid 8328219)